Dr. Sulaiman Al Habib Medical Services Group Company
4013
주식 순위
#1118
Headquartered in Riyadh, Saudi Arabia, Dr. Sulaiman Al Habib Medical Services... Headquartered in Riyadh, Saudi Arabia, Dr. Sulaiman Al Habib Medical Services Group Company, established in 1993, specializes in the development, management, and operation of a wide spectrum of healthcare facilities across the Kingdom. Its extensive portfolio encompasses general and specialized hospitals, various medical complexes, outpatient surgical centers, and pharmaceutical facilities. The group operates hospitals focusing on specific areas such as maternity services, orthopedics, and spinal surgeries. Furthermore, it oversees specialized clinics for dermatology, plastic surgery, ophthalmology, obesity treatment, and fertility, complemented by its network of pharmacies. Beyond direct patient care, the company provides home medical services, advanced laboratory diagnostics, technology and information system support, facility upkeep, medical equipment maintenance, and telemedicine solutions.
주가
$59.36
마지막 동기화: 2026-10-15
시가총액
$20.77B
변동 (1일)
0.54%
변동 (1년)
-20.22%
국가
SA
거래 Dr. Sulaiman Al Habib Medical Services Group Company (4013)
카테고리
Healthcare
Dr. Sulaiman Al Habib Medical Services Group Company (4013)의 EPS
June 2026 기준 EPS TTM: $1.84
Dr. Sulaiman Al Habib Medical Services Group Company의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $1.84입니다. 2023년 말에는 회사의 EPS가 $1.56였으며, 이는 2022년의 EPS $1.26와 증가입니다.
Dr. Sulaiman Al Habib Medical Services Group Company의 EPS 기록 (2015 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $1.84 | 4.69% |
| 2024 | $1.76 | 12.78% |
| 2023 | $1.56 | 24.24% |
| 2022 | $1.26 | 19.96% |
| 2021 | $1.05 | 30.04% |
| 2020 | $0.81 | 21.27% |
| 2019 | $0.66 | 8.75% |
| 2018 | $0.61 | 22.40% |
| 2017 | $0.50 | -35.28% |
| 2016 | $0.77 | -23.85% |
| 2015 | $1.01 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $29.96 | 1,526.05% |
US
|
|
| - | - |
DE
|
|
| $26.12 | 1,317.64% |
US
|
|
| - | - |
MY
|
|
| $0.42 | -77.20% |
BR
|
